News

ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update

Key Highlights: Second research site selected to enhance enrollment in the Phase 2a clinical trial for Cholesterol Efflux MediatorTM VAR…

2 years ago

Yield10 Bioscience Announces Delisting from Nasdaq

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company,…

2 years ago

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

2 years ago

Delivra Health and its Brands Dream Water TM and LivRelief TM Report Positive Adjusted EBITDA(1) for Third Quarter of Fiscal 2024

Vancouver, British Columbia--(Newsfile Corp. - May 15, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or…

2 years ago

Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board Member

STOCKHOLM, SWEDEN / ACCESSWIRE / May 15, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB, a pharmaceutical company that develops…

2 years ago

Empowering Research: Bioz and IBA Lifesciences Collaborate to Showcase Publication Data on IBA Lifesciences’ Website

PALO ALTO, CA / ACCESSWIRE / May 15, 2024 / Bioz, Inc., a leading AI software company committed to scientific…

2 years ago

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on…

2 years ago

Pulse Biosciences Enhances Executive Leadership Team

Appoints proven atrial fibrillation medical technology leader Burke T. Barrett as President and Chief Executive Officer Former President and Chief…

2 years ago

Glenwood Regional Medical Center’s Status Restored by CMS and Fully Operational

State health officials determine facility is in substantial compliance and continuing to serve patients and community 24/7WEST MONROE, La.--(BUSINESS WIRE)--Glenwood…

2 years ago

Bausch Health Announces Updates Related to Norwich XIFAXAN Matters

LAVAL, QC / ACCESSWIRE / May 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business Salix Pharmaceuticals,…

2 years ago